Viscosupplementation (biosupplementation) for osteoarthritis

American Journal of Physical Medicine and Rehabilitation

Volumn 85, Issue 11 SUPPL., 2006, Pages

  Stitik, Todd P ^a   Levy, Joshua A ^b  

^a RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

^b Pain and Interventional Nerve Block Specialists   (United States)

Author keywords

Arthritis; Biosupplementation; Osteoarthritis; Viscosupplementation

Indexed keywords

HYALURONIC ACID; STEROID; TRIAMCINOLONE ACETONIDE;

ANTIINFLAMMATORY ACTIVITY; ANTINOCICEPTION; ANTIOXIDANT ACTIVITY; APPLICATION SITE INFLAMMATION; APPLICATION SITE SWELLING; ARTICULAR CARTILAGE; CARTILAGE MATRIX; DOG; DRUG EFFECT; DRUG EFFICACY; DRUG MECHANISM; DRUG SAFETY; DRUG TOLERABILITY; EXTRACELLULAR MATRIX; FOOD AND DRUG ADMINISTRATION; GRANULOMATOSIS; GRANULOMATOUS INFLAMMATION; HUMAN; INJECTION SITE PAIN; INJECTION SITE SWELLING; INJECTION SITE WARMTH; KNEE FUNCTION; KNEE OSTEOARTHRITIS; KNEE PAIN; LONG TERM CARE; MUSCLE STRENGTH; NONHUMAN; OSTEOARTHRITIS; PSEUDOGOUT; PSEUDOSARCOMA; RABBIT; REVIEW; SHEEP; SYNOVIAL FLUID; SYNOVIUM; VISCOSITY;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; BIOMECHANICS; HUMANS; HYALURONIC ACID; OSTEOARTHRITIS; RHEOLOGY; SYNOVIAL FLUID; VISCOSITY;

EID: 33750629749     PISSN: 08949115     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.phm.0000245677.20294.c2     Document Type: Review

References (159)

1. Bellamy N, Campbell J, Robinson V, Gee T, Bourne R, Wells G: Viscosupplementation for the treatment of osteoarthritis of the knee. Cochrane Database Syst Rev 2006; (2):CD005321
2. Recommendations for the medical management of osteoarthritis of the hip and knee: 2000 update. American College of Rheumatology Subcommittee on Osteoarthritis Guidelines. Arthritis Rheum 2000;43:1905-15
3. Kelly MA, Goldberg VM, Healy WL, Pagnano MW, Hamburger MI: Osteoarthritis and beyond: a consensus on the past, present, and future of hyaluronans in orthopedics. Orthopedics 2003;26:1064-81
4. Neustadt DH: Long-term efficacy and safety of intra-articular sodium hyaluronate (Hyalgan) in patients with osteoarthritis of the knee. Clin Exp Rheumatol 2003;21:307-11
5. Altman D: Laboratory findings in osteoarthritis, in Moskowitz, Howell, D Goldberg V Mankin J, eds: Osteoarthritis: Diagnosis and Medical Surgical Management, ed 2. Philadelphia: WB Saunders, 1992, 313-28
6. Balazs EA: The physical properties of synovial fluid and the special role of hyaluronic acid, in Helfet A, ed: Disorders of the Knee. Philadelphia: Lippincott, 1974, 61-74
7. Asheim A, Lindblad G: Intra-articular treatment of arthritis in run horses with sodium hyaluronate. Acta Vet Scand 1976;(Suppl 17):379-94
8. Namiki O, Toyoshima H, Morisaki N: Therapeutic effect of intra-articular injection of high molecular weight hyaluronic acid on osteoarthritis of the knee. Int J Clin Pharmacol Ther Toxicol 1982;20:501-7
9. Tew WP: Sodium hyaluronate and the treatment of equine joint disorders, in Milne FJ, ed: Proceedings of the 30th Annual Meeting of the American Association of Equine Practioners, Dallas, 1984, pp 67-86
10. Cannon JH: Clinical evaluation of intra-articular sodium hyaloronate in the thoroughbred race horse. J Equine Vet Sci 1985;5:147-8
11. Irwin DHG: Sodium hyaloronate in equine traumatic arthritis. J S Afr Vet Assoc 1980;50:231-3
12. Nizolek DJH, White KK: Corticosteriod and hyaluronic acid treatments in equine degenerative joint disease: a review. Cornell Vet 1981;71:355-75
13. Galley RH: The use of hyaluronic acid in the race horse, in Milne FJ, ed: Proceedings of the 32nd Annual Meeting of the American Association of Equine Practioners. Nashville, 1986, pp 657-61
14. Auer JA, Fackelman GE, Gingerich DA, Fetter AW: Effect of hyaluronic acid in naturally occurring and experimentally induced osteoarthritis. Am J Vet Res 1980;41:568-74
15. Ghosh P, Guidolin D: Potential mechanism of action of intra-articular hyaluronan therapy in osteoarthritis: are the effects molecular weight dependent? Semin Arthritis Rheum 2002;32:10-37
16. Balazs E: The physical properties of synovial fluid and the specific role of hyaluronic acid, in Helfet AJ, ed: Disorders of the Knee. Philadelphia: JB Lippincott, 1982, pp 61-74
17. Mensitieri M, Ambrosio L, Iannace S, Nicolais L: Viscoelastic evaluation of different knee osteoarthritis therapies. J Mat Sci Mat Med 1995;6:130-7
18. Grecomoro G, La Sala F, Francavilla G: Rheologic changes in the synovial fluid of patients with gonarthritis induced by intraarticular infiltration of hyaluronic acid. Int J Tissue React 2001;23:67-71
19. Gotoh S, Miyazaki K, Onaya J, et al: Experimental knee pain model in rats and analgesic effect of sodium hyaluronate. Folia Pharm 1988;92:17-27
20. Pozo MA, Balazs EA, Belmonte C: Reduction of sensory responses to passive movements of inflamed knee joints by hylan, a hyaluronan derivative. Exp Brain Res 1997;116:3-9
21. de la Peña E, Pecson B, Schmidt RF, Belmonte C: Effects of hylans on the response characteristics of mechanosensitive ion channels. Presented at the 9th World Congress on Pain, Vienna, Austria, 1999
22. Aihara S, Murakami N, Ishii R, et al: [Effects of sodium hyaluronate on the nociceptive response of rats with experimentally induced arthritis]. Nippon Yakurigaku Zasshi 1992;100:359-65
23. Moore AR, Willoughby DA: Hyaluronan as a drug delivery system for diclofenac: a hypothesis for mode of action. Int J Tissue React 1995;17:153-6
24. Engstrom-Laurent A: Hyaluronan in joint disease. J Intern Med 1997;242:57-60
25. Moreland LW: Intra-articular hyaluronan (hyaluronic acid) and hylans for the treatment of osteoarthritis: mechanisms of action. Arthritis Res Ther 2003;5:54-67
26. Dougados M, Nguyen M, Listrat V, Amor B: High molecular weight sodium hyauronate in knee OA. 1-year placebo-controlled trial. Osteoarthr Cartil 1993;1:97-103
27. Punzi L, Schiavon F, Cavasin F, et al: The influence of intraarticular hyaluronic acid on PGE2 and cAMP of synovial fluid. Clin Exp Rheumatol 1989;7:247-50
28. Tobetto K, Yasui T, Ando T, et al: Inhibitory effects of hyaluronan on [14C]arachidonic acid release from labeled human synovial fibroblasts. Jpn J Pharmacol 1992;60:79-84
29. 2 production in human osteoarthritis synovial cells. Agents Actions 1992;37:155-6
30. Presti D, Scott JE: Hyaluronan-mediated protective effect against cell damage caused by enzymatically produced hydroxyl (OH) radicals is dependent on hyaluronan molecular mass. Cell Biochem Funct 1994;12:281-8
31. Comer JS, Kincaid SA, Baird AN, Kammermann JR, Hanson RR Jr, Ogawa Y: Immunolocalization of stromelysin, tumor necrosis factor (TNF) alpha, and TNF receptors in atrophied canine articular cartilage treated with hyaluronic acid and transforming growth factor beta. Am J Vet Res 1996;57:1488-96
32. Hirota W: Intra-articular injection of hyaluronic acid reduces total amounts of leukotriene C4, 6-keto-prostaglandin F1alpha, prostaglandin F2alpha and interleukin-1beta in synovial fluid of patients with internal derangement in disorders of the temporomandibular joint. Br J Oral Maxillofac Surg 1998;36:35-8
33. Takahashi K, Goomer RS, Harwood F, Kubo T, Hirasawa Y, Amiel D: The effects of hyaluronan on matrix metalloproteinase-3 (MMP-3), interleukin-1beta (IL-1beta), and tissue inhibitor of metalloproteinase-1 (TIMP-1) gene expression during the development of osteoarthritis. Osteoarthr Cartil 1999;7:182-90
34. Nonaka T, Kikuchi H, Ikeda T, Okamoto Y, Hamanishi C, Tanaka S: Hyaluronic acid inhibits the expression of u-PA, PAI-1, and u-PAR in human synovial fibroblasts of osteoarthritis and rheumatoid arthritis. J Rheumatol 2000;27:997-1004
35. Goto M, Hanyu T, Yoshio T, et al: Intra-articular injection of hyaluronate (SI-6601D) improves joint pain and synovial fluid prostaglandin E2 levels in rheumatoid arthritis: a multicenter clinical trial. Clin Exp Rheumatol 2001;19:377-83
36. Pellitier JP, Martel-Pelletier J: The pathophysiology oof osteoarthritis and the implication of the use of hyaluronan and hylan as therapeutic agents in viscosupplementation. J Rheumatol 1993;20(Suppl 39):19-24
37. Yasui T, Akatsuka M, Tobetto K, et al: Effects of hyaluronan on the production of stromelysin and tissue inhibitor of metalloproteinase-1 (TIMP-1) in bovine articular chondrocytes. Biomed Res 1992;13:343-8
38. Fukuda K, Takayama M, Ueno M, et al: Hyaluronic acid inhibits interleukin-1-induced superoxide anion in bovine chondrocytes. Inflamm Res 1997;46:114-7
39. Fukuda K, Oh M, Asada S, et al: Sodium hyaluronate inhibits interleukin-1-evoked reactive oxygen species of bovine articular chondrocytes. Osteoarthr Cartil 2001;9:390-2
40. Sato H, Takahashi T, Ide H, et al: Antioxidant activity of synovial fluid, hyaluronic acid, and two subcomponents of hyaluronic acid. Arthritis Rheum 1988;31:63-71
41. Moseley R, Leaver M, Walker M, et al: Comparison of the antioxidant properties of HYAFF®-11p75 AQUACEL® and hyaluronan towards reactive oxygen species in vitro. Biomaterials 2002;23:2255-64
42. Takahashi K, Hashimoto S, Kubo T, Hirasawa Y, Lotz M, Amiel D: Hyaluronan suppressed nitric oxide production in the meniscus and synovium of rabbit osteoarthritis model. J Orthop Res 2001;19:500-3
43. Peluso G, Perbellini A, Tajana G: The effect of high and low molecular weight hyaluronic acid on mitogen-induced lymphocyte proliferation. Curr Ther Res 1990;47:437-43
44. Darzynkiewicz Z, Balazs EA: Effect of connective tissue intercellular matrix on lymphocyte stimulation. 1. Suppression of lumphocyte stimulation by hyaluronic acid. Exp Cell Res 1971;66:113-23
45. Corrado EM, Peluso GF, Gigliotti S, et al: The effects of intra-articular administration of hyaluronic acid on osteoarthritis of the knee: a clinical study with immunological and biochemical evaluations. Eur J Rheumatol Inflamm 1995;15:47-56
46. Hakansson L, Hallgren R, Verge P: Regulation of granulocyte function by hyaluronic acid. In vitro and in vivo effects on phagocytosis, locomotion, and metabolism. J Clin Invest 1980;66:298-305
47. Partsch G, Schwaarzer C, Neumuller J, et al: Modulation of the migration and chemotaxis of PMN cells by hyaluronic acid. Z. Rheumatol 1989;48:123-8
48. Pisko E, Turner R, Soderstrom L, Panetti M: Inhibition of neutrophils, phagocytosis and enzyme release by hyaluronic acid. Clin Exp Rheumatol 1983;1:1-14
49. Forrester J, Balazs E: Inhibition of phagocytosis by high molecular weight hyaluronate. Immunology 1980;40:435-43
50. Balazs EA, Darzynkiewicz Z: The efffect of hyaluronic acid on fibroblasts, mononuclear phagocytes and lumphocytes, in Kulonen E, Pikkarainen J, eds.: Biology of the Fibroblast. London: Academic Press, 1973, pp 237-52
51. Sezgin M, Demirel AC, Karaca C, et al: Does hyaluronan affect inflammatory cytokines in knee osteoarthritis? Rheumatol Int 2005;25:264-9
52. Shimizu M, Yasuda T, Nakagawa T, et al: Hyaluronan inhibits matrix metalloproteinase-1 production by rheumatoid synovial fibroblasts stimulated by proinflammatory cytokines. J Rheumatol 2003;30:1164-72
53. Wiig ME, Amiel D, VandeBerg J, Kitabayashi L, Harwood FL, Arfors KE: The early effect of high molecular weight hyaluronan (hyaluronic acid) on anterior cruciate ligament healing: an experimental study in rabbits. J Orthop Res 1990;8:425-34
54. Frizziero L, Govoni E, Bacchini P: Intra-articular hyaluronic acid in the treatment of osteoarthritis of the knee: clinical and morphological study. Clin Exp Rheumatol 1998;16:441-9
55. Forrester JV, Lackie JM: Effect of hyaluronic acid on neutrophil adhesion. J Cell Sci 1981;50:329-44
56. Tobetto K, Nakai K, Akatsuka M, et al: Inhibitory effects of hyaluronan on neutrophil-mediated cartilage degradation. Connect Tissue Res 1993;29:181-90
57. Balazs E, Briller S, Denlinger J: Na-hyaluronate molecular size variations in equine arthritis and human arthritic synovial fluids and the effect on phagocytic cells, in Talbott J, ed.: Seminars in Arthritis and Rheumatism, vol. 11. New York: Grune & Stratton, 1981, pp 141-3
58. Pasquali Ronchetti I, Guerra D, Taparelli F, et al: Morphological analysis of knee synovial membrane biopsies from a randomized controlled clinical study comparing the effects of sodium hyaluronate (Hyalgan) and methylprednisolone acetate (Depomedrol) in osteoarthritis. Rheumatology 2001;40:158-69
59. Swanstrom OG: Hyaluronate (hyaluronic acid) and its use, in Milne FJ, ed: Proceedings of the 24th Annual Meeting of the American Association of Equine Practioners, St. Louis, 1978, pp 345-8
60. Nizolek DJ, White KK: Corticosteroid and hyaluronic acid treatments in equine degenerative joint disease. A review. Cornell Vet 1981;71:355-75
61. Smith MM, Ghosh P: The synthesis of hyaluronic acid by human synovial fibroblasts is influenced by the nature of the hyaluronate in the extracellular environment. Rheumatol Int 1987;7:113-22
62. Vuorio E, Einola S, Hakkarainen S, Penttinen R: Synthesis of under-polymerised hyaluronic acid by fibroblasts cultured from rheumatoid and non-rheumatoid synovitis. Rheumatol Int 1982;2:97-102
63. Ishida O, Tanaka Y, Morimoto I, Takigawa M, Eto S: Chondrocytes are regulated by cellular adhesion through CD44 and hyaluronic acid pathway. J Bone Miner Res 1997;12:1657-63
64. Hulmes DJS, Marsden ME, Strachan RK, Harvery RE, McInnes N, Gardner DL: Intra-articular hyaluronate in experimental rabbit osteoarthritis can prevent changes in cartilage proteoglycan content. Osteoarthr Cartil 2004;12:232-8
65. Kikuchi T, Yamada H, Shimmei M: Effect of high molecular weight hyaluronan on cartilage degradation in a rabbit model of osteoarthritis. Osteoarthr Cartil 1996;4:99-110
66. Takahashi K, Hashimoto S, Kubo T, Hirasawa Y, Lotz M, Amiel D: Effect of hyaluronan on chondrocyte apoptosis and nitric oxide production in experimentally induced osteoarthritis. J Rheumatol 2000;27:1713-20
67. Lisignoli G, Grassi F, Zini N, Toneguzzi S, Piacentini A, Guidolin D, et al: Anti-fas-induced apoptosis in chondrocytes reduced by hyaluronan. Evidence for CD44 and CD54 (intercellular adhesion molecule 1) involvement. Arthritis Rheum 2001;44:1800-7
68. Larsen N, Lombard K, Parent E, Balazs E: Effect of hylan on cartilage and chondrocyte cultures. J Orthoped Res 1992;10:23-32
69. Marshall KW: The current status of hylan therapy for the treatment of osteoarthritis. Today's Therapeutic Trends 1997;15:99-108
70. Weiss C, Suros J, Dennis J, et al: Effect of Na-hylan on articular cartilage. Proceedings of the Orthopedic Research Society, Las Vegas, 1989, p 539
71. Lussier A, Bellamy N: Viscosupplementation as a treatment option in the management of osteoarthritis. J Clin Rheumatol 1999;5:S1-2
72. Weiss C, Band P: Basic principles underlying the development of viscosupplementation for the treatment of osteoarthritis. J Clin Rheumatol 1999;5:S2-11
73. Culty M, Miyake K, Kincade PW, Sikorski E, Butcher EC, Underhill C: The hyaluronate receptor is a member of the CD44 (H-CAM) family of cell surface glycoproteins. J Cell Biol 1990;111:2765-74
74. Tamoto K, Tada M, Shimada S, Nochi H, Mori Y: Effects of high-molecular-weight hyaluronates on the functions of guinea pig polymorphonuclear leukocytes. Semin Arthritis Rheum 1993;22(6 Suppl 1):4-8
75. Greenberg DD, Stoker A, Kane S, Cockrell M, Cook JL: Biochemical effects of two different hyaluronic acid products in a co-culture model of osteoarthritis. Osteoarthr Cartil 2006;14:814-22
76. Schaible HG, Schmidt RF: Effects of an experimental arthritis on the sensory properties of fine articular afferent units. J Neurophysiol 1985;54:1109-22
77. Tung JT, Venta PJ, Caron JP: Inducible nitric oxide expression in equine articular chondrocytes: effects of antiinflammatory compounds. Osteoarthr Cartil 2002;10:5-12
78. Fioravanti A, Cantarini L, Chellini F, et al: Effect of hyaluronic acid (MW 500-730 kDa) on proteoglycan and nitric oxide production in human osteoarthritic chondrocyte cultures exposed to hydrostatic pressure. Osteoarthr Cartil 2005;13:688-96
79. Ohkawara Y, Tamura G, Iwasaki T, Tanaka A, Kikuchi T, Shirato K: Activation and transforming growth factor-beta production in eosinophils by hyaluronan. Am J Respir Cell Mol Biol 2000;23:444-51
80. Peyron JG, Balazs EA: Preliminary clinical assessment of Na-hyaluronate injection into human arthritic joints. Pathol Biol 1976;22:731-6
81. Balazs EA, Denlinger JL: Sodium hyaluronic acid and joint function. J Equine Vet Sci 1985;5:217-28
82. Rydell NW, Butler J, Balazs EA: Hyaluronic acid in synovial fluid. VI: Effect of intra-articular injection of hyaluronic acid on the clinical symptoms of arthritis in track horses. Acta Vet Scand 1970;11:139-55
83. Rydell N, Balazs E: Effect of intra-articular injection of hyaluronic acid on the clinical symptoms of osteoarthritis and on granulation tissue formation. Clin Orthoped Relat Res 1971;80:25-32
84. Asheim A, Lindblad G: Intra-articular treatment of arthritis in race-horses with sodium hyaluronate. Acta Vet Scand 1976;17:379-94
85. Phillips MW: Clinical trial comparison of intra-articular sodium hyaluronate products in the horse. J Equine Vet Sci 1989;9:39-40
86. Gingerich DA, Auer JA, Fackerman CE: Effects of exogenous hyaluronic acid on joint function in experimentally induced equine osteoarthritis: dosage titration studies. Res Vet Sci 1981;30:192-7
87. Bellamy N, Campbell J, Robinson V, Gee T, Bourne R, Wells G: Viscosupplementation for the treatment of osteoarthritis of the knee. Cochrane Database Syst Rev 2005; (2):CD005321
88. Arrich J, Piribauer F, Mad P, Schmid D, Klaushofer K, Mullner M: Intra-articular hyaluronic acid for the treatment of osteoarthritis of the knee: systematic review and meta-analysis. CMAJ 2005;172:1039-43
89. Wang CT, Lin J, Chang CJ, Lin YT, Hou SM: Therapeutic effects of hyaluronic acid on osteoarthritis of the knee. A meta-analysis of randomized controlled trials. J Bone Joint Surg Am 2004;86A:538-45
90. Lo GH, LaValley M, McAlindon T, Felson DT: Intra-articular hyaluronic acid in treatment of knee osteoarthritis: a meta-analysis. JAMA 2003;290:3115-21
91. Maheu E, Ayral X, Dougados M: A hyaluronan preparation (500-730 kDa) in the treatment of osteoarthritis: a review of clinical trials with Hyalgan. Int J Clin Pract 2002;56:804-13
92. Kirchner M, Marshall D: A double-blind randomized controlled trial comparing alternate forms of high molecular weight hyaluronan for the treatment of osteoarthritis of the knee. Osteoarthr Cartil 2006;14:154-62
93. Deleted in proof
94. Stitik TP: Viscosupplementation for Osteoarthritis. In: Physical Medicine and Rehabilitation State of the Art Reviews. Osteoarthritis. Stitik TP (Ed.). 2000;15:117-45
95. Neustadt DH: Long-term efficacy and safety of intra-articular sodium hyaluronate (Hyalgan) in patients with osteoarthritis of the knee. Clin Exp Rheumatol 2003;21:307-11
96. Kolarz G, Kotz R, Hochmayer I: Long-term benefits and repeated treatment cycles of intra-articular sodium hyaluronate (Hyalgan) in patients with osteoarthritis of the knee. Semin Arthritis Rheum 2003;32:310-9
97. Raynauld JP, Torrance GW, Band PA, et al: A prospective, randomized, pragmatic, health outcomes trial evaluating the incorporation of hylan G-F 20 into the treatment paradigm for patients with knee osteoarthritis (Part 1 of 2): clinical results. Osteoarthr Cartil 2002;10:506-17
98. Tasciotaoglu F, Oner C: Efficacy of intra-articular sodium hyaluronate in the treatment of knee osteoarthritis. Clin Rheumatol 2003;22:112-7
99. Caborn D, Rush J, Lanzer W, et al: A randomized, single-blind comparison of the efficacy and tolerability of hylan G-F 20 and triamcinolone hexacetonide in patients with osteoarthritis of the knee. J Rheumatol 2004;31:333-43
100. Bayramoglu M, Karatas M, Cetin N, Akman N, Sozay S, Dilek A: Comparison of two different viscosupplements in knee osteoarthritis-a pilot study. Clin Rheumatol 2003;22:118-22
101. Stitik TP, et al: Intra-articular hyaluronan therapy and concomitant home exercise strengthening - an additive therapeutic algorithm for osteoarthritis of the knee. Archives of PM&R 2004. Available at www.aapmr-archives-pmr.org) e9. Accessed September 28, 2006
102. Tang SF, Chen CP, Chen MJ, Hong WH, Yu TY, Tsai WC: Improvement of muscle strength in osteoarthritic knee patients after intraarticular knee injection of hyaluronan. Am J Phys Med Rehabil 2005;84:274-7
103. Yavuzer G, Sonel B, Suldur N, Ergin S: Effects of intraarticular hylan G-F 20 injections on clinical and biomechanical characteristics of the knee in osteoarthritis. Int J Rehabil Res 2005;28:371-4
104. Cubukcu D, Ardic F, Karabulut N, Topuz O, Hylan G-F: 20 efficacy on articular cartilage quality in patients with knee osteoarthritis: clinical and MRI assessment. Clin Rheumatol 2005;24:336-41
105. Waddell DD, Cefalu CA, Bricker DC: A second course of hylan G-F 20 for the treatment of osteoarthritic knee pain: 12-month patient follow-up. J Knee Surg 2005;18:7-15
106. Vad VB, Bhat AL, Sculco TP, Wickiewicz TL: Management of knee osteoarthritis: knee lavage combined with hylan versus hylan alone. Arch Phys Med Rehabil 2003;84:634-7
107. Kotevoglu N, Iyibozkurt PC, Hiz O, Toktas H, Kuran B: A prospective randomized controlled clinical trial comparing the efficacy of different molecular weight hyaluronan solutions in the treatment of knee osteoarthritis. Rheumatol Int 2006;26:325-30
108. Karlsson J, Sjogren LS, Lohmander LS: Comparison of two hyaluronan drugs and placebo in patients with knee osteoarthritis. A controlled, randomized, double-blind, parallel-design multicentre study. Rheumatology (Oxford) 2002;41:1240-8
109. Huang MH, Yang RC, Lee CL, Chen TW, Wang MC: Preliminary results of integrated therapy for patients with knee osteoarthritis. Arthritis Rheum 2005;53:812-20
110. Bellamy N, Campbell J, Robinson V, Gee T, Bourne R, Wells G: Intraarticular corticosteroid for treatment of osteoarthritis of the knee. Cochrane Database Syst Rev 2006;(2):CD005328
111. Felson DT: Nonmedicinal therapies for osteoarthritis. Bull Rheum Dis 1998;47:5-7
112. Chamberlain MA, Care G, Harfield B: Physiotherapy in osteoarthritis of the knees: a controlled trial of hospital versus home exercises. Int Rehabil Med 1982;4:101-6
113. Feinberg J, Marzouk D, Sokolek C, Katz B, Bradley J, Brandt K: Effects of isometric versus range of motion exercise on joint pain and function in patients with knee osteoarthritis [Abstract]. Arthritis Rheum 1992;35(Suppl 5):R28
114. Jan MH, Lai JS: The effects of physiotherapy on osteoarthritic knees of females. J Formos Med Assoc 1993;90:1008-13
115. Forster MC, Straw R: A prospective randomised trial comparing intra-articular Hyalgan injection and arthroscopic washout for knee osteoarthritis. Knee 2003;10:291-3
116. Petrella RJ: Hyaluronic acid for the treatment of knee osteoarthritis: long-term outcomes from a naturalistic primary care experience. Am J Phys Med Rehabil 2005;84:278-83
117. Scali JJ: Intra-articular hyaluronic acid in the treatment of osteoarthritis of the knee: a long-term study. Eur J Rheumatol Inflamm 1995; 15:57-62
118. Conrozier T, Mathieu P, Schott AM, et al: Factors predicting long-term efficacy of Hylan GF-20 viscosupplementation in knee osteoarthritis. Joint Bone Spine 2003;70:128-33
119. Toh EM, Prasad PS, Teanby D: Correlating the efficacy of knee viscosupplementation with osteoarthritic changes on roentgenological examination. Knee 2002;9:321-30
120. Jubb RW, Piva S, Beinat L, Dacre J, Gishen P: A randomised, placebo (saline)-controlled clinical trial of the structure modifying effect of 500-730 KDa sodium hyaluronate (Hyalgan) in osteoarthritis of the knee Int J Clin Pract 2003;57:467-74
121. Listrat V, Ayral X, Patarnello F, et al: Arthroscopic evaluation of potential structure modifying activity of hyaluronan (hyalgan) in osteoarthritis of the knee. Osteoarthr Cartil 1997;5:153-60
122. Carrabba M, Paresce E, Angelini M, Re KA, Torchiaa EEM, Perbellini A: The safety and efficacy of different dose schedules of hyaluronic acid in the treatment of painful osteoarthritis of the knee with joint effusion. Eur J Rheumatol Inflamm 1995;15:25-31
123. Guidolin DD, Ronchetti IP, Lini E, Guerra D, Frizziero L: Morphological analysis of articular cartilage biopsies from a randomized, clinical study comparing the effects of 500-730 kDa sodium hyaluronate (Hyalgan) and methylprednisolone acetate on primary osteoarthritis of the knee. Osteoarthr Cartil 2001;9:371-81
124. Jubb RW, Piva S, Beinat L, Dacre J, Gishen P, for the UK Hyalgan study group: Clinical trial to examine the effect of HA on articular cartilage through changes in radiological joint space. Presented at the Annual European Congress of Rheumatology European League against Rheumatology, Prague, Czech Republic, June 13-16, 2001
125. Marshall KW, Manolopoulos V, Mancer K, Staples J, Damyanovich A: Amelioration of disease severity by intraarticular hylan therapy in bilateral canine osteoarthritis. J Orthop Res 2000;18:416-25
126. Shimizu C, Yoshioka M, Coutts RD, et al: Long-term effects of hyaluronans on experimental osteoarthritis in a rabbit knee. Osteoarthr Cartil 1998;6:1-9
127. Goldberg VM, Buckwalter JA: Hyaluronans in the treatment of osteoarthritis of the knee: evidence for diseasemodifying activity. Osteoarthr Cartil 2005;13:216-24
128. Peterfy C, Kothari M: Imaging osteoarthritis: magnetic resonance imaging versus x-ray. Curr Rheumatol Rep 2006;8:16-21
129. 128a. Kawasaki K, Ochi M, Uchio Y, Adachi N, Matsusaki M: Hyaluronic acid enhances proliferation and chondroitin sulfate synthesis in cultured chondrocytes embedded in collagen gels. J Cell Physiol 1999;179:142-8
130. Frean SP, Abraham LA, Lees P: In vitro stimulation of equine articular cartilage proteoglycan synthesis by hyaluronan and carprofen. Res Vet Sci 1999;67:183-90
131. Fukuda K, Dan H, Takayama M, et al: Hyaluronic acid increases proteoglycan synthesis in bovine articular cartilage in the presence of interleukin-1. J Pharmacol Exp Ther 1996;277:1672-5
132. Stove J, Gerlach C, Huch K, Gunther KP, Puhl W, Scharf HP: Effects of hyaluronan on proteoglycan content of osteoarthritic chondrocytes in vitro. J Orthop Res 2002;20:551-5
133. Ghosh P, Holbert C, Read R, Armstrong S: Hyaluronic acid (hyaluronan) in experimental osteoarthritis. J Rheumatol Suppl 1995;43:155-7
134. Creamer P, Sharif M, George E, et al: Intra-articular hyaluronic acid in osteoarthritis of the knee: an investigation into mechanisms of action. Osteoarthr Cartil 1994;2:133-40
135. Yoshioka M, Shimizu C, Harwood FL, Coutts RD, Amiel D: The effects of hyaluronan during the development of osteoarthritis. Osteoarthr Cartil 1997;5:251-60
136. Shimazu A, Jikko A, Iwamoto M, et al: Effects of hyaluronic acid on the release of proteoglycan from the cell matrix in rabbit chondrocyte cultures in the presence and absence of cytokines. Arthritis Rheum 1993;36:247-53
137. Homandberg GA, Hui F, Wen C, et al: Hyaluronic acid suppresses fibronectin fragment mediated cartilage chondrolysis: I. In vitro. Osteoarthr Cartil 1997;5:309-19
138. Kang Y, Eger W, Koepp H, et al: Hyaluronan suppresses fibronectin fragment-mediated damage to human cartilage explant cultures by enhancing proteoglycan synthesis. J Orthopaed Res 1999;17:858-69
139. Williams JM, Plaza V, Hui F, Wen C, Kuettner KE, Homandberg GA: Hyaluronic acid suppresses fibronectin fragment mediated cartilage chondrolysis: II. In vivo. Osteoarthr Cartil 1997;5:235-40
140. Amiel D, Toyoguchi T, Kobayashi K, Bowden K, Amiel ME, Healey RM: Long-term effect of sodium hyaluronate (Hyalgan) on osteoarthritis progression in a rabbit model Osteoarthr Cartil 2003:636-43
141. Kobayashi K, Amiel M, Harwood FL, et al: The long-term effects of hyaluronan during development of osteoarthritis following partial meniscectomy in a rabbit model. Osteoarthr Cartil 2000;8:359-365
142. Maniwa S, Ochi M, Motomura T, Nishikori T, Chen J, Naora H: Effects of hyaluronic acid and basic fibroblast growth factor on motility of chondrocytes and synovial cells in culture. Acta Orthop Scand 2001;72:299-303
143. Fu LL, Maffulli N, Chan KM: Intra-articular hyaluronic acid following knee immobilisation for 6 weeks in rabbits. Clin Rheumatol 2001;20:98-103
144. Wenz W, Breusch SJ, Graf J, Stratmann U: Ultrastructural findings after intraarticular application of hyaluronan in a canine model of arthropathy. J Orthop Res 2000;18:604-12
145. Armstrong S, Read R, Ghosh P: The effects of intraarticular hyaluronan on cartilage and subchondral bone changes in an ovine model of early osteoarthritis. J Rheumatol 1994;21:680-8
146. Frizziero L, Pasquali Ronchetti I: Intra-articular treatment of osteoarthritis of the knee: An arthroscopic and clinical comparison between sodium hyaluronate (500-730 kDa) and methylprednisolone acetate. J Orthop Trauma 2002;3:89-96
147. Hamburger MI, Lakhanpal S, Mooar PA, Oster D: Intraarticular hyaluronans: a review of product-specific safety profiles. Semin Arthritis Rheum 2003;32:296-309
148. Espallargues M, Pons JM: Efficacy and safety of viscosupplementation with Hylan G-F 20 for the treatment of knee osteoarthritis: a systematic review. Int J Technol Assess Health Care 2003;19:41-56
149. Hammesfahr JF, Knopf AB, Stitik T: Safety of intra-articular hyaluronates for pain associated with osteoarthritis of the knee. Am J Orthop 2003;32:277-83
150. Pagnano M, Westrich G: Successful nonoperative management of chronic osteoarthritis pain of the knee: safety and efficacy of retreatment with intra-articular hyaluronans. Osteoarthr Cartil 2005;13:751-61
151. Altman RD, Moskowitz R, for the Hyalgan Study Group: Intraarticular sodium hyaluronate (Hyalgan) in the treatment of patients with osteoarthritis of the knee: a randomized clinical trial. J Rheumatol 1998;25:2203-12
152. Sodium hyaluronate (MW 500-730 kDa). Product information pamphlet. Sanofi-Synthelabo. 2001
153. Synvisc: Synvisc product labeling (prescribing information). Philadelphia, PA: Wyeth-Ayerst, 2000
154. Goldberg VM, Coutts RD: Pseudoseptic reactions to hylan viscosupplementation: diagnosis and treatment Clin Orthop 2004;19:130-7
155. Hamburger M, Settles M, Teutsch J: Identification of an immunogenic candidate for the elicitation of severe acute inflammatory reactions (SAIRs) to hylan G-F 20. Osteoarthr Cartil 2005;13:266-8
156. Chen AL, Desai P, Adler EM, Di Cesare PE: Granulomatous inflammation after Hylan G-F 20 viscosupplementation of the knee: a report of six cases J Bone Joint Surg Am 2002;84A:1142-7
157. Michou L, Job-Deslandre C, de Pinieux G, Kahan A: Granulomatous synovitis after intraarticular Hylan GF-20. A report of two cases. Joint Bone Spine 2004;71:438-40
158. Zardawi IM, Chan I: Synvisc perisynovitis. Pathology 2001;33:519-20
159. Jones KB, Patel PP, Deyoung BR, Buckwalter JA: Viscosupplementation pseudotumor. A case report. J Bone Joint Surg Am 2005;87:1113-9